Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01797380 · ClinicalTrials.gov registry record · Phase 4
A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01797380 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 5 participants.
The verdict
NCT01797380, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
To determine the efficacy of escitalopram in treating depression in HIV seropositive women.
Interventions
- DRUG Placebo
- DRUG Escitalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01797380
The ClinicalTrials.gov registry entry for NCT01797380 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01797380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01797380 about?
NCT01797380 is a clinical study titled "A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women". To determine the efficacy of escitalopram in treating depression in HIV seropositive women.
What is the current status of trial NCT01797380?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2008-01. Estimated completion is 2009-04.
What interventions are being tested in trial NCT01797380?
The interventions under investigation include: Placebo (DRUG), Escitalopram (DRUG).
Who is sponsoring clinical trial NCT01797380?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.